Evidence map›Paper›PMID 29774835›Full record

ArticleEmerging infectious diseases2018

Bioclinical Test to Predict Nephropathia Epidemica Severity at Hospital Admission.

Maxime Hentzien, Stéphanie Mestrallet, Pascale Halin, Laure-Anne Pannet, Delphine Lebrun, Moustapha Dramé, Firouzé Bani-Sadr, Jean-Marc Galempoix, Christophe Strady, Jean-Marc Reynes and 2 more

Registry-linked trialAbstract readMulticenter Study
PubMed Full text at PMC Publisher
In one paragraph

Article in Emerging infectious diseases, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02455375 (Puumala Hantavirus Infection in France), which is not on this map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02455375 completednot on this map

Puumala Hantavirus Infection in France: Evaluation of Commercial Assays for the Detection of Antibodies Against This Virus and the Use of Urine Samples for the Molecular Detection of This Infection

TypeobservationalSponsorCentre Hospitalier de Charleville-MézièresRan2015 to 2021Enrolled179ConditionsNephropathia Epidemica, Hemorrhagic Fever With Renal Syndrome
3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Maxime Hentzien
Stéphanie Mestrallet
Pascale Halin
Laure-Anne Pannet
Delphine Lebrun
Moustapha Dramé
Firouzé Bani-Sadr
Jean-Marc Galempoix
Christophe Strady
Jean-Marc Reynes
Christian Penalba
Amélie Servettaz

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We conducted a multicenter, retrospective cohort study of hospitalized patients with serologically proven nephropathia epidemica (NE) living in Ardennes Department, France, during 2000-2014 to develop a bioclinical test predictive of severe disease. Among 205 patients, 45 (22.0%) had severe NE. We found the following factors predictive of severe NE: nephrotoxic drug exposure (p = 0.005, point value 10); visual disorders (p = 0.02, point value 8); microscopic or macroscopic hematuria (p = 0.04, point value 7); leukocyte count >10 × 10

Indexed as

AdultBiomarkersComorbidityDiagnostic Tests, RoutineFemaleHemorrhagic Fever with Renal SyndromeHospitalizationHumansMaleMiddle AgedOdds RatioPrognosisRetrospective StudiesROC CurveSeverity of Illness IndexSymptom AssessmentBiomarkersacute kidney injurycohort studiesdisease severityEuropeFrancehantavirushematuriahemorrhagic diseasehospital admissionleukocytosisnephropathia epidemicanephrotoxic drug exposureprognosisPuumala virusrisk factorsthrombocytopeniavirusesvisual disorder

Identifiers

PMID29774835
PMCPMC6004848

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.